Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 339-343

  Valensi, Paul ^a   Sachs, Regis Nessim ^a   Harfouche, Boubakeur ^a   Lormeau, Boris ^a   Paries, Jacques ^a   Cosson, Emmanuel ^a   Paycha, Frédéric ^c   Leutenegger, Marc ^b   Attali, Jean Raymond ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ARTICLE; AUTONOMIC NEUROPATHY; DIABETES MELLITUS; DIABETIC NEUROPATHY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR;

EID: 0035142650     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.339     Document Type: Article

References (24)

1. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
2. Prevalence of asymptomatic myocardial ischemia in diabetic patients
3. Detection of silent myocardial ischemia in diabetes mellitus
4. Silent myocardial ischemia and left ventricle hypertrophy in diabetic patients
5. Impairment of coronary vascular reserve and acetylcholine-induced coronary vasodilation in diabetic patients with aniographically normal coronary arteries and normal left ventricular systolic function
6. Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment
7. Factors involved in cardiac autonomic neuropathy in diabetic patients
8. Asymptomatic coronary artery disease in diabetes: Associated with autonomic neuropathy?
9. Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: An exercise electrocardiography study in middle-aged diabetic men
10. Should silent ischemia be treated in asymptomatic individuals?
11. Coronary disease and diabetes: Recommendations of ALFEDIAM
12. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
13. Silent ischaemia in diabetic men with autonomic neuropathy
14. A study of peripheral diabetic neuropathy: The application of age-related reference values
15. Why and how should cardiovascular autonomic neuropathy in the diabetic be researched?
16. Reproducibility of parameters for assessment of diabetic neuropathy
17. Initial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischemia and angiographically documented coronary artery disease (the Oslo Ischemia Study)
18. Silent ischemia predicts infarction and death during two-year follow-up of unstable angina
19. Value of ambulatory ST segment monitoring in patients with chronic stable angina: Does measurement of the "total ischemic burden" assist with management?
20. Prognostic implications of myocardial ischemia during daily life in low risk patients with coronary artery disease
21. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: A report from the Coronary Artery Surgery Study (CASS) registry
22. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients: Prognostic value of exercise stress test and thallium-201 singlephoton emission computed tomography
23. Diabetic autonomic neuropathy: What are the risks?
24. Autonomic neuropathy in the diabetic patient: Recommendations of ALFEDIAM